Matches in SemOpenAlex for { <https://semopenalex.org/work/W2929683886> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2929683886 abstract "The disease Psoriasis was comparatively studied with the disease Kalanjaga padai. In considering the following three important facts that, Psoriasis has been linked to an increased risk of stroke and atrial fibrillation (ole Ahuhoff et al., 2011), its important complication in many patients is psoriatic arthritis (Gelfand IM et al., 2005) and Long term toxicities are observed with all currently available system treatments (European Medicine agency Journal), it is a need to evaluate the safe and effective drug for the treatment of psoriasis. For this a clinical trial with internal medicine Neeradi muthu vallathy melugu and external medicine kalapai kilangu velipoochu in meeting the disease psoriasis was conducted.For this 40 cases were selected. The pre clinical studies of the trial drug were found to be encouraging.Out of 40 cases 30 were treated in OPD and remaining 10 in IPD of Govt. Siddha Medical College & Hospital Palayamkottai. Some of the complementary therapies were followed along the course of the treatment. Complete proforma was maintained for each and every patient. Daily progress was observed to note the clinical efficacy of the drug. The results obtained were found to be auspicious.Pre clinical pharmacological analysis of the trial drug had1. Significant anti histamine action.2. Significant acute anti inflammatory actions.3. Moderate chronic anti-inflammatory actions.4. Significant analgesic actionNo adverse reactions like nausea, vomiting, diarrhoea, abdominal discomfort, drowsiness were reported during the study period. Hence the trial drug was found to be safe and effective.CONCLUSION:In this clinical study “Neeradi muthu vallathy melugu” and “kalapai kilangu velipuchu” were taken as Internal & External drug respectively for treating the disease Kalanjaga padai.The Overall results of efficacy of the trial drugs along with complementary therapies by reducing the clinical signs and symptoms like Itching, Scaling and erythema in this Clinical study were found to be Good in 67.5% cases, Moderate in 25% cases and Mild in 7.5%. The costs of the trial medicines are relatively economical. The raw drugs are easily available and the preparation is also convenient. No adverse effects and side effects were found clinically for the trial drugs. So the study proved conclusively that the clinical effects of the trial drugs were found to be good in treating the disease Psoriasis." @default.
- W2929683886 created "2019-04-11" @default.
- W2929683886 creator A5051001610 @default.
- W2929683886 date "2013-04-01" @default.
- W2929683886 modified "2023-09-27" @default.
- W2929683886 title "A Study on Kalanjagapadai" @default.
- W2929683886 cites W2024697012 @default.
- W2929683886 cites W2051879593 @default.
- W2929683886 hasPublicationYear "2013" @default.
- W2929683886 type Work @default.
- W2929683886 sameAs 2929683886 @default.
- W2929683886 citedByCount "0" @default.
- W2929683886 crossrefType "dissertation" @default.
- W2929683886 hasAuthorship W2929683886A5051001610 @default.
- W2929683886 hasConcept C126322002 @default.
- W2929683886 hasConcept C16005928 @default.
- W2929683886 hasConcept C177713679 @default.
- W2929683886 hasConcept C197934379 @default.
- W2929683886 hasConcept C2776556288 @default.
- W2929683886 hasConcept C2780035454 @default.
- W2929683886 hasConcept C2780564577 @default.
- W2929683886 hasConcept C2780580376 @default.
- W2929683886 hasConcept C2780852908 @default.
- W2929683886 hasConcept C535046627 @default.
- W2929683886 hasConcept C556039675 @default.
- W2929683886 hasConcept C71924100 @default.
- W2929683886 hasConcept C98274493 @default.
- W2929683886 hasConceptScore W2929683886C126322002 @default.
- W2929683886 hasConceptScore W2929683886C16005928 @default.
- W2929683886 hasConceptScore W2929683886C177713679 @default.
- W2929683886 hasConceptScore W2929683886C197934379 @default.
- W2929683886 hasConceptScore W2929683886C2776556288 @default.
- W2929683886 hasConceptScore W2929683886C2780035454 @default.
- W2929683886 hasConceptScore W2929683886C2780564577 @default.
- W2929683886 hasConceptScore W2929683886C2780580376 @default.
- W2929683886 hasConceptScore W2929683886C2780852908 @default.
- W2929683886 hasConceptScore W2929683886C535046627 @default.
- W2929683886 hasConceptScore W2929683886C556039675 @default.
- W2929683886 hasConceptScore W2929683886C71924100 @default.
- W2929683886 hasConceptScore W2929683886C98274493 @default.
- W2929683886 hasLocation W29296838861 @default.
- W2929683886 hasOpenAccess W2929683886 @default.
- W2929683886 hasPrimaryLocation W29296838861 @default.
- W2929683886 hasRelatedWork W2115679882 @default.
- W2929683886 hasRelatedWork W2146447031 @default.
- W2929683886 hasRelatedWork W2348077722 @default.
- W2929683886 hasRelatedWork W2367080957 @default.
- W2929683886 hasRelatedWork W2368645093 @default.
- W2929683886 hasRelatedWork W2435247457 @default.
- W2929683886 hasRelatedWork W2603903506 @default.
- W2929683886 hasRelatedWork W2889049607 @default.
- W2929683886 hasRelatedWork W2897373764 @default.
- W2929683886 hasRelatedWork W2908873258 @default.
- W2929683886 hasRelatedWork W2909337790 @default.
- W2929683886 hasRelatedWork W2910551171 @default.
- W2929683886 hasRelatedWork W2945184963 @default.
- W2929683886 hasRelatedWork W3029578243 @default.
- W2929683886 hasRelatedWork W3046998091 @default.
- W2929683886 hasRelatedWork W3047607459 @default.
- W2929683886 hasRelatedWork W3120108780 @default.
- W2929683886 hasRelatedWork W3165593182 @default.
- W2929683886 hasRelatedWork W2037660125 @default.
- W2929683886 hasRelatedWork W2185841895 @default.
- W2929683886 isParatext "false" @default.
- W2929683886 isRetracted "false" @default.
- W2929683886 magId "2929683886" @default.
- W2929683886 workType "dissertation" @default.